Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENSE-COV: Lopinavir/ritonavir with Telmisartan or Atorvastatin for COVID-19
NCT04466241Phase 3Completed
- Sponsor
- ANRS
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, atorvastatin in coronavirus disease 2019 (COVID-19), sponsored by ANRS. Started Nov 2020; status: completed.
02
Drugs
telmisartanatorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04466241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466241.